Institutional investors purchased a net $217.1 thousand shares of SRDX during the quarter ended March 2015 and now own 91.18% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SMITH ASSET MANAGEMENT GROUP LP Bought 800.00 shares of SurModics Inc
MERISTEM LLP Bought 519.00 shares of SurModics Inc
GLENMEDE INVESTMENT MANAGEMENT L... Bought 196.00 shares of SurModics Inc